Fig. 6: APOH expression associates with sorafenib response in patients with liver cancer. | Cell Death & Disease

Fig. 6: APOH expression associates with sorafenib response in patients with liver cancer.

From: Serum apolipoprotein H determines ferroptosis resistance by modulating cellular lipid composition

Fig. 6

Expression of SLC7A11 (A), GPX4 (B), APOH (C), and SCD (D) were evaluated in patients with HCC hepatocellular carcinoma, they were categorized as 21 responders and 46 non-responders to sorafenib treatment using the GEO dataset (GSE109211). The statistical difference of the two groups was compared through the t-test. **P < 0.01, ****P < 0.0001.

Back to article page